The company specializes in developing enhanced versions of existing drug products and providing services to enable pre-clinical and clinical stage formulations for their clients' drugs. They improve the bioavailability of poorly water-soluble medicine by creating either polymeric or crystalline nanoparticles using their proprietary MJR® Technology platform. Leon-nanodrugs offers access to the next generation of nano-formulated drugs with meaningful differentiation and added patient benefits. They also offer highly flexible GMP manufacturing solutions for genetic payloads and other molecules, making manufacturing of transfection material a highly flexible and commercially viable proposition. Leon-nanodrugs is working with world-class industry partners for both process and product development.